Menu Search
Equities

Nexus AG

NXU:FRA

Nexus AG

Actions
  • Price (EUR)51.70
  • Today's Change0.40 / 0.78%
  • Shares traded250.00
  • 1 Year change+0.78%
  • Beta--
Data delayed at least 15 minutes, as of May 02 2024 08:17 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Nexus AG is a Germany-based developer of software for the health care sector. Among others, the Company provides Nexus/HIS, an information system that supports the administrative and medical/nursing areas in hospitals; Nexus/Obstetrics, a documentation software for pregnancies; is also focusing on digital pathology which controls the processes from material entry to billing; Nexus/Psychiatry, a solution for psychiatric institutions from treating patients to key figure management for institution management; CWD - Clinic WindData (E&L), a diagnostics software for the areas of endoscopy, cardiology, sonography and ophthalmology; Nexus/Home, an information system that features finance, resident and treatment management, as well as staff deployment, and Nexus/Curator, a Web-based knowledge database for quality management with document management in health care. The Company operates through subsidiaries in Austria, France, Spain, Switzerland, the Netherlands and Poland, among others.

  • Revenue in EUR (TTM)241.46m
  • Net income in EUR24.03m
  • Incorporated1999
  • Employees1.69k
  • Location
    Nexus AGIrmastrasse 1DONAUESCHINGEN 78166GermanyDEU
  • Phone+49 771229600
  • Fax+49 77 122960999
  • Websitehttps://www.nexus-ag.de/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.